• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (OP: SILO )

    N/A UNCHANGED
    Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Silo Pharma Inc

    < Previous 1 2 3 4 Next >
    Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO), UMB Collaborating on Potentially Significant Homing-Peptide Technology
    Via Investor Brand Network
    Study Says Ayahuasca Users Tend to Exercise More, Eat Healthier
    Via Investor Brand Network
    Topics Religion
    Exposures Religion
    Study Finds That Microdosing Psilocybin Mushrooms Improves Mood, Mental Health
    Via Investor Brand Network
    Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease
    Via Investor Brand Network
    Study Suggests COVID-19 Increases Parkinson’s Disease Risk
    Via Investor Brand Network
    Exposures COVID-19
    New Research Suggests Mental Disorders Magnify Dementia Risk
    Via Investor Brand Network
    Study Maps How Brain Changes During Treatment for Depression
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study
    Via Investor Brand Network
    DEA Sets Hearing Date Regarding Plan to Ban Several Psychedelics
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope, Possible Therapeutic to Alzheimer’s Patients
    Via Investor Brand Network
    Federal Health Agencies Admit That Classification of Psychedelics Is Impeding Research
    Via Investor Brand Network
    Brain Cell Regulation Mechanism Could Unlock Novel Treatment Modalities for Neurological Conditions
    Via Investor Brand Network
    New Report Says Smoking Amplifies Schizophrenia and Depression Risk
    Via Investor Brand Network
    What Investors Interested in Psychedelics Need to Focus on Regarding IP Issues
    Via Investor Brand Network
    Topics Cannabis Intellectual Property
    Exposures Cannabis Intellectual Property
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Expansion of License Agreement and Patent Portfolio
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Study Finds Frequent Nightmares May Be Sign of Parkinson’s Disease Development
    Via Investor Brand Network
    New Study Finds Dose Tapering May Heighten Risk of Opioid Overdoses
    Via Investor Brand Network
    Mystical Experiences Due to Psilocybin Linked to Positive Mental Well-Being
    Via Investor Brand Network
    Study Says Damage to Neurons, Not Plaque Triggers Alzheimer’s Onset
    Via Investor Brand Network
    Topics Death
    Exposures Death
    Five Books on Psychedelics You May Enjoy Reading
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Committed to Psilocybin, Anti-Inflammatory Research
    Via Investor Brand Network
    Study Offers New Insights into Psilocybin’s Mechanism for Treating Depression
    Via Investor Brand Network
    At least 4 in 10 Long-COVID Patients Report Symptoms Akin to Fibromyalgia
    Via Investor Brand Network
    Exposures COVID-19
    UK Firm Develops Inhaler to Facilitate Psychedelic Microdosing
    Via Investor Brand Network
    UC Davis Awarded Grant to Find New Non-hallucinogenic Psychedelic Treatments for Addiction
    Via Investor Brand Network
    Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties
    Via Investor Brand Network
    Davos Hosts Psychedelic Medical Series
    Via Investor Brand Network
    Exposures COVID-19
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope to Patients Suffering from Alzheimer’s and Potentially Other Ailments
    Via Investor Brand Network
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.